Chemoembolization, Therapeutic
"Chemoembolization, Therapeutic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm.
| Descriptor ID |
D016461
|
| MeSH Number(s) |
E02.520.360.150 E02.926.500.150
|
| Concept/Terms |
Chemoembolization, Therapeutic- Chemoembolization, Therapeutic
- Therapeutic Chemoembolization
- Chemoembolizations, Therapeutic
- Therapeutic Chemoembolizations
|
Below are MeSH descriptors whose meaning is more general than "Chemoembolization, Therapeutic".
Below are MeSH descriptors whose meaning is more specific than "Chemoembolization, Therapeutic".
This graph shows the total number of publications written about "Chemoembolization, Therapeutic" by people in this website by year, and whether "Chemoembolization, Therapeutic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemoembolization, Therapeutic" by people in Profiles.
-
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study. J Immunother Cancer. 2022 06; 10(6).
-
Single center analysis of therapy and outcomes of hepatocellular carcinoma in Sub-Saharan Africa. Expert Rev Gastroenterol Hepatol. 2020 Oct; 14(10):1007-1011.
-
Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization. Eur J Radiol. 2017 Aug; 93:100-106.
-
EUS-guided portal vein interventions. Gastrointest Endosc. 2017 05; 85(5):883-888.
-
Racial disparities in treatment and survival of hepatocellular carcinoma in native Americans and Hispanics. Am J Surg. 2017 Jul; 214(1):100-104.
-
Earlier presentation and application of curative treatments in hepatocellular carcinoma. Hepatology. 2014 Nov; 60(5):1637-44.
-
Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma. Radiology. 2014 Aug; 272(2):587-97.
-
Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials. J Vasc Interv Radiol. 2013 Aug; 24(8):1189-1197.e2.
-
Solitary fibrous tumor in solid organs: still a challenging diagnosis. Am Surg. 2012 Jun; 78(6):E322-4.
-
Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. Gastroenterology. 2011 Aug; 141(2):526-35, 535.e1-2.